HEI - Eligibility
AI-assisted patient pre-screening for complex chronic disease trials

Reduce enrollment delays before they impact trial timelines

Reduce preventable screen failures, improve enrollment predictability, and support audit-ready eligibility workflows — without replacing clinical coordinators.

See how it works

Designed for sponsors, CROs, and trial sites. Human-in-the-loop by design.

Workflow support for clinical operations
AI
assisted eligibility review
Practical workflow layer • not autonomous decision-making

Enrollment delays are expensive

Clinical trial teams lose time and budget when screen failures surface too late and eligibility review depends on fragmented manual workflows across EHRs, spreadsheets, emails, and coordinator review processes.
1
Patients fail eligibility late in the screening process
2
Coordinators manually review complex inclusion/exclusion criteria
3
Enrollment projections become unreliable
4
Protocol deviations create additional QA and IRB burden
The result
Delayed milestones

Enrollment targets slip and activation plans become harder to manage.

More admin work

Teams spend time on repetitive review, follow-up, and documentation.

Timeline volatility

Trial execution becomes harder to forecast across sites and cohorts.

Audit risk

Inconsistent rationale and communication records increase operational exposure.

A workflow support layer for clinical operations teams

Our platform helps sponsors, CROs, and trial sites identify likely screen failures earlier through AI-assisted eligibility review integrated into existing workflows.

Designed for human-in-the-loop review, audit-ready documentation, existing EHR and site workflows, and complex chronic disease trial criteria.

Clinical teams remain the final decision-makers.

Reduce preventable screen failures

Flag potential eligibility mismatches earlier in the enrollment workflow.

Improve enrollment predictability

Support more reliable forecasting across enrollment milestones and site activation timelines.

Reduce coordinator administrative burden

Decrease repetitive manual eligibility review and documentation tasks.

Support audit and compliance workflows

Maintain structured eligibility rationale and communication records for QA and IRB processes.

Built for modern clinical trial operations

A minimal, operationally practical layer that supports execution without adding another disconnected system to already complex study workflows.
Sponsors

Improve visibility into enrollment risk and trial execution variability.

CROs

Reduce operational friction and support more efficient site management.

Trial Sites

Help coordinators manage eligibility workflows without adding another disconnected system.

Early Access Program

We're currently speaking with

Sponsors
CRO clinical operations teams
Site networks
Regulatory and QA stakeholders

to validate workflows for AI-assisted eligibility review and enrollment risk reduction.

If enrollment delays and screen failures are active challenges in your trials, we'd like to learn from your team.

Request Early Access

See how AI-assisted eligibility review may help reduce enrollment delays and improve operational predictability.

Frequently Asked Questions

Clear guardrails matter. This product is designed to support operational teams while preserving clinical oversight and documented decision-making.
Does the platform replace clinical coordinators?

No. The system is designed to support clinical teams, not replace human decision-making.

Is this connected to EHR systems?

We are exploring integrations that fit existing clinical workflows and reduce administrative burden.

Is the platform making autonomous eligibility decisions?

No. Clinical teams remain responsible for final eligibility determination and oversight.

Who is this designed for?

Sponsors, CROs, and trial sites managing complex Phase I–III clinical trials.

Reduce delays. Improve predictability.

Request early access to explore how AI-assisted eligibility review can help your team reduce preventable screen failures and support more reliable trial operations.